DK2231166T3 - Fedtsyrer med medium kædelængde, salte og triglycerider i kombination med gemcitabin til behandling af pankreascancer - Google Patents

Fedtsyrer med medium kædelængde, salte og triglycerider i kombination med gemcitabin til behandling af pankreascancer

Info

Publication number: DK2231166T3
Authority: DK; Denmark
Prior art keywords: gemcitabine; triglycerides; salts; treatment; medium
Prior art date: 2007-12-19

Application number

DK08862479.6T

Other languages

English (en)

Inventor

Lyne Gagnon

Lilianne Geerts

Christopher Penney

Original Assignee

Prometic Biosciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-19

Filing date

2008-12-18

Publication date

2013-06-24

2008-12-18 Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc

2013-06-24 Application granted granted Critical

2013-06-24 Publication of DK2231166T3 publication Critical patent/DK2231166T3/da

Links

206010061902 Pancreatic neoplasm Diseases 0.000 title 1
SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 title 1
229960005277 gemcitabine Drugs 0.000 title 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 title 1
150000004667 medium chain fatty acids Chemical class 0.000 title 1
201000002528 pancreatic cancer Diseases 0.000 title 1
208000008443 pancreatic carcinoma Diseases 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
150000003626 triacylglycerols Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK08862479.6T 2007-12-19 2008-12-18 Fedtsyrer med medium kædelængde, salte og triglycerider i kombination med gemcitabin til behandling af pankreascancer DK2231166T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US812907P	2007-12-19	2007-12-19
PCT/CA2008/002190 WO2009076761A1 (en)	2007-12-19	2008-12-18	Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer

Publications (1)

Publication Number	Publication Date
DK2231166T3 true DK2231166T3 (da)	2013-06-24

Family

ID=40795145

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08862479.6T DK2231166T3 (da)	2007-12-19	2008-12-18	Fedtsyrer med medium kædelængde, salte og triglycerider i kombination med gemcitabin til behandling af pankreascancer

Country Status (15)

Country	Link
US (1)	US8946190B2 (da)
EP (1)	EP2231166B1 (da)
JP (1)	JP5473937B2 (da)
KR (1)	KR101603351B1 (da)
CN (1)	CN101903028B (da)
AU (1)	AU2008338204B2 (da)
BR (1)	BRPI0821395A2 (da)
CA (1)	CA2708679C (da)
DK (1)	DK2231166T3 (da)
ES (1)	ES2414617T3 (da)
MX (1)	MX2010006867A (da)
NZ (1)	NZ586249A (da)
PT (1)	PT2231166E (da)
TW (1)	TWI448290B (da)
WO (1)	WO2009076761A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA022445B1 (ru)	2009-05-04	2016-01-29	Прометик Байосайенсиз Инк.	Замещенные ароматические соединения, композиции на их основе и их фармацевтические применения
CN105997967B (zh) *	2010-10-27	2019-08-23	普罗米蒂克医药Smt有限公司	用于治疗癌症的化合物和组合物
CN102617679B (zh) *	2012-03-13	2014-11-26	北京大学	一种共轭亚油酸与吉西他滨连接的前体药物制备方法及其应用
WO2014126969A1 (en)	2013-02-12	2014-08-21	Bend Research, Inc.	Solid dispersions of low-water solubility actives
US9737538B2 (en)	2013-02-12	2017-08-22	Bend Research, Inc.	Solid dispersions of low-water solubility actives
MX377728B (es)	2013-02-28	2025-03-11	Pronova Biopharma Norge As	Composición que comprende un compuesto lípido, un triglicerido y un tensioactivo, y métodos de uso de la misma.
WO2015116782A1 (en)	2014-01-29	2015-08-06	Board Of Regents, The University Of Texas System	Nucleobase analogue derivatives and their applications
SG11202103011YA (en)	2018-10-11	2021-04-29	Basf As	Aromatic compounds and pharmaceutical uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE168557T1 (de) *	1989-03-13	1998-08-15	Cellegy Pharma Inc	Topische zubereitungen enthaltend aliphatische amine zur behandlung von hautkrankheiten
US6340705B1 (en) *	1999-09-10	2002-01-22	Monsanto Technology, Llc	Use of α-linolenic acid metabolites for treatment or prevention of cancer
JP5026655B2 (ja) *	2001-04-18	2012-09-12	プロメティック、バイオサイエンシーズ、インコーポレーテッド	好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体
EP1427366A2 (en) *	2001-08-29	2004-06-16	UMD, Inc.	Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
US20060012880A1 (en) *	2002-05-02	2006-01-19	Law Benjamin P	Optical device with refractive and diffractive properties
ATE419846T1 (de) *	2003-02-07	2009-01-15	Prometic Biosciences Inc	Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese
ES2264886B1 (es) *	2005-05-12	2008-02-01	Proyecto Empresarial Brudy, S.L.	Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.

2008
- 2008-12-18 CN CN2008801221273A patent/CN101903028B/zh not_active Expired - Fee Related
- 2008-12-18 DK DK08862479.6T patent/DK2231166T3/da active
- 2008-12-18 NZ NZ586249A patent/NZ586249A/en not_active IP Right Cessation
- 2008-12-18 JP JP2010538291A patent/JP5473937B2/ja not_active Expired - Fee Related
- 2008-12-18 KR KR1020107015015A patent/KR101603351B1/ko not_active Expired - Fee Related
- 2008-12-18 AU AU2008338204A patent/AU2008338204B2/en not_active Ceased
- 2008-12-18 BR BRPI0821395-0A patent/BRPI0821395A2/pt not_active IP Right Cessation
- 2008-12-18 MX MX2010006867A patent/MX2010006867A/es active IP Right Grant
- 2008-12-18 TW TW097149396A patent/TWI448290B/zh not_active IP Right Cessation
- 2008-12-18 EP EP08862479A patent/EP2231166B1/en not_active Not-in-force
- 2008-12-18 CA CA2708679A patent/CA2708679C/en active Active
- 2008-12-18 ES ES08862479T patent/ES2414617T3/es active Active
- 2008-12-18 PT PT88624796T patent/PT2231166E/pt unknown
- 2008-12-18 WO PCT/CA2008/002190 patent/WO2009076761A1/en not_active Ceased
- 2008-12-18 US US12/809,380 patent/US8946190B2/en active Active

Also Published As

Publication number	Publication date
TW200934494A (en)	2009-08-16
WO2009076761A1 (en)	2009-06-25
CN101903028A (zh)	2010-12-01
KR101603351B1 (ko)	2016-03-14
TWI448290B (zh)	2014-08-11
CA2708679A1 (en)	2009-06-25
US8946190B2 (en)	2015-02-03
EP2231166A4 (en)	2012-02-22
JP5473937B2 (ja)	2014-04-16
KR20100101134A (ko)	2010-09-16
HK1151244A1 (en)	2012-01-27
AU2008338204B2 (en)	2015-03-05
EP2231166A1 (en)	2010-09-29
US20100273731A1 (en)	2010-10-28
EP2231166B1 (en)	2013-03-20
ES2414617T3 (es)	2013-07-22
PT2231166E (pt)	2013-06-17
CN101903028B (zh)	2013-06-05
AU2008338204A1 (en)	2009-06-25
NZ586249A (en)	2012-05-25
BRPI0821395A2 (pt)	2015-06-16
CA2708679C (en)	2016-11-15
MX2010006867A (es)	2010-08-31
JP2011506492A (ja)	2011-03-03

Publication	Publication Date	Title
DK2231166T3 (da)	2013-06-24	Fedtsyrer med medium kædelængde, salte og triglycerider i kombination med gemcitabin til behandling af pankreascancer
DK2114419T3 (da)	2014-06-10	Natriummetaarsenit til anvendelse i behandling af smerte og inflammation
DK2193198T3 (da)	2014-09-01	Varmestabil asparaginase til reduktion af acrylamid i levneds- eller nydelsesmidler
DK2473510T3 (da)	2014-10-20	Jak-2-hæmmere og anvendelse heraf til behandling af myeloproliferativesygdomme og cancer
BRPI0818287A2 (pt)	2015-11-03	células dendríticas manipuladas e usos para o tratamento do câncer.
DK2483278T3 (da)	2014-01-13	Benzoxazepin pi3k-inhibitorforbindelser og deres anvendelse i behandlingen af cancer
DK2350416T4 (da)	2019-07-15	Multipel rude med mindst én antirefleksbehandling og anvendelse af antirefleksbehandling i multipel rude
BRPI0807717A2 (pt)	2014-05-20	Inibidores de quinase úteis para o tratamento de doenças mieloproliferativas e outras doenças proliferativas.
EP2124771A4 (en)	2012-03-14	DEVICES AND METHODS FOR EXTRACORPORAL ABLATION OF CIRCULATING CELLS
DK2155188T3 (da)	2013-11-04	Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft
DK1732562T3 (da)	2008-04-28	Substituerede pyridinyl- og pyrimidinylderivater som modulatorer af metabolisme og behandling af forstyrrelser relateret dertil
DK2127652T3 (da)	2013-06-10	Fremgangsmåde til behandling af cancer under anvendelse af anticancermiddel i kombination
DK2426106T3 (da)	2013-11-04	Piperidin- og piperazinderivat til behandling af tumorer
DK3095447T3 (da)	2022-01-31	Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3
DK2259674T3 (da)	2014-08-04	Delta-4-desaturase og anvendelse heraf i fremstillingen af flerumættedefedtsyrer
DK2235002T3 (da)	2013-03-11	4-pyridinonforbindelser og anvendelse heraf til behandling af cancer
BRPI0921022A2 (pt)	2015-12-29	tratamento com pirfenidona para pacientes com função hepática atípica
DK2342233T3 (da)	2014-09-29	Anti-CXCR4-antistoffer og anvendelse deraf i behandling af cancer
IL202424A (en)	2017-01-31	Telomerase activating compounds for use in treating diseases, disorders and conditions related thereto
DK2101805T3 (da)	2013-01-21	Integrinligander til anvendelse i behandling af cancer
DK2297106T3 (da)	2014-10-06	Phenoxypyridinylamidderivater og deres anvendelse til behandling af pde4-medierede sygdomstilstande
DK2063881T3 (da)	2019-08-12	Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer
BRPI0816712A2 (pt)	2016-11-08	terapia de intervalo para o tratamento de tinnitus
DK2313404T3 (da)	2012-06-04	Quinuclidin-carbonat-derivater og medicinsk sammensætning deraf
DK2158201T3 (da)	2011-08-01	Derivater af 7-alkynyl-1,8-naphthyridon, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapi